0000014272-17-000065.txt : 20170307 0000014272-17-000065.hdr.sgml : 20170307 20170307163933 ACCESSION NUMBER: 0000014272-17-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170303 FILED AS OF DATE: 20170307 DATE AS OF CHANGE: 20170307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEUNG SANDRA CENTRAL INDEX KEY: 0001199294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 17672483 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 4 1 wf-form4_148892276044701.xml FORM 4 X0306 4 2017-03-03 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001199294 LEUNG SANDRA BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 EVP, General Counsel Common Stock, $0.10 par value 2017-03-03 4 M 0 116100 27.01 A 488063.3322 D Common Stock, $0.10 par value 2017-03-06 4 S 0 92405 57.016 D 395658.3322 D Common Stock, $0.10 par value 5847.1498 I By BMY Savings and Investment Program Option (right to buy) 27.01 2017-03-03 4 M 0 116100 0 D 2017-03-05 Common Stock, $0.10 par value 116100.0 0 D A portion of the proceeds from the sale of these shares were used to cover the exercise price and taxes of the Option exercised on March 3, 2017. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $56.64 to $57.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Based on a plan statement as of the end of the most recent fiscal quarter. All of the shares are currently exercisable. /s/ Katherine Kelly, attorney-in-fact for Sandra Leung 2017-03-07